Companies: 10,795·Total market cap: $144.5T
Tiziana Life Sciences Ltd

Tiziana Life Sciences Ltd

TLSANASDAQHealthcare● Active
$1.22
$-0.02(-1.61%)
Market Cap$72499720
P/E Ratio—
52W High$2.6
52W Low$1.08
SEC Filings
Foreign Private Issuer · Files 20-F / 6-K

Tiziana Life Sciences Ltd (TLSA) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001723069 · TLSA · NASDAQ · as of Jun 9, 2026

Filing snapshot

467
Total Filings
6-K
Latest Form
2026-05-28
Most Recent
2018
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001723069 · Updated hourly · Not investment advice

Latest Annual Report

20-F · Annual Report (Foreign Issuer)FY
Filed Date
2026-05-01
Fiscal Year End
May 1, 2026
Accession No.
0001213900-26-051015
Primary Document
ea0287936-20f_tiziana.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001723069 · Accession 0001213900-26-051015

Latest Key Filings

6-KQuarterly Report
REPORT OF FOREIGN PRIVATE ISSUER
2026-05-28
View 6-K on SEC
8-KCurrent Report
CURRENT REPORT
2021-10-21Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-05-28
View
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2026-05-22
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-05-21
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-05-19
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-05-14
View
20-FAnnual Report (Foreign Issuer)
ANNUAL REPORT
2026-05-01
View
NT 20-FNT 20-F
NOTIFICATION OF LATE FILING
2026-04-30
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-04-16
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-04-14
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-04-01
View
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2026-03-18
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-02-25
View
S-8Employee Stock Plan Registration
REGISTRATION STATEMENT
2026-02-20
View
424B5424B5
PROSPECTUS SUPPLEMENT
2026-01-22
View
AWAW
WITHDRAWAL OF AMENDMENT
2026-01-22
View
Showing 1–15 of 467 filingsForm 4 / 144 hidden

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001723069  |  Exchange: NASDAQ · Healthcare

Tiziana Life Sciences Ltd (NASDAQ: TLSA) has submitted 467 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2018. As a Healthcare sector company with CIK 0001723069, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Tiziana Life Sciences Ltd's most comprehensive regulatory disclosure. The most recent Tiziana Life Sciences Ltd 10-K was filed on 2026-05-01 for fiscal year ending 2026. Historical TLSA 10-K annual reports are available from 2017 through 2026.

Investors researching Tiziana Life Sciences Ltd SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-09
Related Companies SEC Filings — Healthcare
IMMX SEC Filings →ZNTL SEC Filings →MGNX SEC Filings →WHWK SEC Filings →COYA SEC Filings →EXOZ SEC Filings →PLRX SEC Filings →OKYO SEC Filings →
→ TLSA Financials→ TLSA Earnings→ TLSA Insider Trades

Frequently Asked Questions

TLSA SEC Filings · 8 questions

Tiziana Life Sciences Ltd (TLSA) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 467 filings and access original documents at no cost. Tiziana Life Sciences Ltd's CIK is 0001723069.

TLSA SEC filingsTiziana Life Sciences Ltd SEC documentsfind TLSA 10-K